FG
ARCB icon

Formula Growth’s ArcBest ARCB Stock Holding History

Formula Growth’s Portfolio ARCB Stock Details ARCB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-18,838
Closed -$1.85M – 146
2026
Q1 		$1.85M Sell
18,838
-32,000
-63% -$3.03M 0.84% 43
2025
Q4 		$3.77M Sell
50,838
-15,800
-24% -$1.12M 1.45% 15
2025
Q3 		$4.66M Buy
66,638
+4,505
+7% +$339K 1.66% 15
2025
Q2 		$4.78M Buy
62,133
+12,486
+25% +$813K 1.81% 10
2025
Q1 		$3.5M Buy
49,647
+8,108
+20% +$702K 1.42% 14
2024
Q4 		$3.88M Buy
41,539
+2,445
+6% +$258K 1.31% 27
2024
Q3 		$4.24M Sell
39,094
-6,000
-13% -$659K 1.46% 21
2024
Q2 		$4.83M Buy
45,094
+6,399
+17% +$771K 1.75% 13
2024
Q1 		$5.51M Sell
38,695
-12,890
-25% -$1.69M 1.76% 13
2023
Q4 		$6.2M Buy
51,585
+985
+2% +$109K 1.99% 3
2023
Q3 		$5.14M Buy
50,600
+23,000
+83% +$2.41M 1.76% 7
2023
Q2 		$2.73M Buy
+27,600
New +$2.47M 0.87% 44

Other funds holding ARCB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MRCP
Maple Rock Capital Partners Toronto, Ontario, Canada $5.1B AUM 214.22% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Formula Growth's ARCB Position: Q2 2026 in Review

Formula Growth sold out of ArcBest (ARCB) in Q2 2026, closing a stake of 18,838 shares — an estimated $1.85M sold.

Formula Growth first reported a position in ARCB in Q2 2023 and held it in 12 quarters. The position peaked at $6.2M in Q4 2023. 330 funds tracked by Wall St. Rank hold ARCB as of Q2 2026.

  • Formula Growth reported no remaining ArcBest position as of Q2 2026 after selling out during the quarter.
  • Formula Growth sold 18,838 ArcBest shares in Q2 2026, an estimated $1.85M.
  • Formula Growth first reported a position in ArcBest in Q2 2023 and held it in 12 quarters.
  • Formula Growth's ArcBest position peaked at $6.2M in Q4 2023.
  • 330 funds tracked by Wall St. Rank held ArcBest as of Q2 2026.

Based on Formula Growth's 13F filing for Q2 2026, filed 17 Aug 2026.